42 results on '"Nair VP"'
Search Results
2. Health Professional vs Layperson Values and Preferences on Scarce Resource Allocation.
- Author
-
Buhr RG, Huynh A, Lee C, Nair VP, Romero R, and Wisk LE
- Subjects
- Humans, Female, Aged, Middle Aged, Critical Care, Health Facilities, Resource Allocation, Health Personnel, COVID-19 epidemiology
- Abstract
Importance: COVID-19 prompted rapid development of scarce resource allocation (SRA) policies to be implemented if demand eclipsed health systems' ability to provide critical care. While SRA policies follow general ethical frameworks, understanding priorities of those affected by policies and/or tasked with implementing them is critical., Objective: To evaluate whether community members and health care profesionals (HCP) agree with SRA protocols at the University of California (UC)., Design, Setting, and Participants: This survey study used social media and community-partnered engagement to recruit participants to a web-based survey open to all participants aged older than 18 years who wished to enroll. This study was fielded between May and September 2020 and queried participants' values and preferences on draft SRA policy tenets. Participants were also encouraged to forward the survey to their networks for snowball sampling. Data were analyzed from July 2020 to January 2024., Main Outcomes and Measures: Survey items assessed values and preferences, graded on Likert scales. Agreement was tabulated as difference in Likert points between expressed opinion and policy tenets. Descriptive statistics were tested for significance by HCP status. Free text responses were analyzed using applied rapid qualitative analysis., Results: A total of 1545 participants aged older than 18 years (mean [SD] age 49 [16] years; 1149 female participants [74%], 478 health care practitioners [30%]) provided data on SRA values and preferences. Agreement with UC SRA policy as drafted was moderately high among respondents, ranging from 67% to 83% across domains. Higher agreement with the interim policy was observed for laypersons across all domains except health-related factors. HCPs agreed more strongly on average that resources should not be allocated to those less likely to survive (HCP mean, 3.70; 95% CI, 3.16-3.59; vs layperson mean, 3.38; 95% CI, 3.17-3.59; P = .002), and were more in favor of reallocating life support from patients less likely to those more likely to survive (HCP mean, 6.41; 95% CI, 6.15-6.67; vs layperson mean, 5.40; 95% CI, 5.23-5.58; P < .001). Transparency and trust building themes were common in free text responses and highly rated on scaled items., Conclusions and Relevance: This survey of SRA policy values found moderate agreement with fundamental principles of such policies. Engagement with communities affected by SRA policy should continue in iterative refinement in preparation for future crises.
- Published
- 2024
- Full Text
- View/download PDF
3. Assessment of urban air quality from Twitter communication using self-attention network and a multilayer classification model.
- Author
-
Kumbalaparambi TS, Menon R, Radhakrishnan VP, and Nair VP
- Subjects
- Humans, Communication, India, Social Media, Air Pollution analysis
- Abstract
Social media platforms are one of the prominent new-age methods used by public for spreading awareness or drawing attention on an issue or concern. This study demonstrates how the twitter responses of public can be used for qualitative monitoring of air pollution in an urban area. Tweets discussing about air quality in Delhi, India, were extracted during 2019-2020 using a machine learning technique based on self-attention network. These tweets were cleaned, sorted, and classified into 3-class quality viz. poor air quality, good air quality, and noise or neutral tweets. The present study used a multilayer classification model with first layer as an embedding layer and second layer as bi-directional long-short term memory (BiLSTM) layer. A method was then devised for estimating PM
2.5 concentration from the tweets using 'spaCy' similarity analysis of classified tweets and data extracted from Continuous Ambient Air Quality Monitoring Stations (CAAQMS) in Delhi for the study period. The accuracy of this estimation was found to be high (80-99%) for extreme air quality conditions (extremely good or severe) and lower during moderate variations in air quality. Application of this methodology depended on perceivable changes in air quality, twitter engagement, and environmental consciousness among public., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
4. Kundalini Yoga Intervention Increases Hippocampal Volume in Older Adults: A Pilot Randomized Controlled Trial.
- Author
-
Ibrahim M, Therriault J, Nair VP, Dikaios E, Rosa-Neto P, Walpola IC, Rej S, and Lifshitz M
- Abstract
Background: Among a rapidly aging population, there is increased need for neuroprotective interventions promoting healthy neurological aging. Mind-body interventions, such as Kundalini yoga, are actively being explored as accessible means to encourage healthy aging. However, little remains known about the neurobiological effects of Kundalini yoga., Aims: This pilot randomized-controlled trial (RCT) examined the potential neuroprotective effects of Kundalini yoga in older adults., Methods: We conducted an RCT with 11 healthy meditation-naïve older adults. Participants were randomized to a Kundalini yoga or psychoeducation intervention. Structural magnetic resonance imaging data were obtained at baseline and 12-week follow-up. The primary outcome measure was gray matter volume of the bilateral hippocampi and bilateral posterior cingulate cortex., Results: We found significant right hippocampal volume increases specific to the Kundalini yoga group ( P = 0.034, η
p 2 = 0.408)., Conclusions: These findings provide initial neurobiological support for the neuroprotective effects of Kundalini yoga., Competing Interests: There are no conflicts of interest., (Copyright: © 2022 International Journal of Yoga.)- Published
- 2022
- Full Text
- View/download PDF
5. A protocol for CRISPR-mediated activation and repression of human endogenous retroviruses in human pluripotent stem cells.
- Author
-
Nair VP, Mayer J, and Vincendeau M
- Subjects
- Clustered Regularly Interspaced Short Palindromic Repeats genetics, Humans, Endogenous Retroviruses genetics, Pluripotent Stem Cells
- Abstract
Human endogenous retroviruses (HERVs) comprise many regulatory elements and can regulate host gene activity at different expression levels via multiple mechanisms. Here, we introduce a step-by-step protocol to activate or repress transcription of HERV-K(HML-2) elements using the CRISPRa and CRISPRi technologies in human embryonic stem cells. This protocol can help deciphering the functional role of HERV-K(HML-2) elements in critical biological processes. The protocol may easily be adapted to other cell lines and HERV groups with relatively low sequence heterogeneity. For complete details on the use and execution of this protocol, please refer to Padmanabhan Nair et al. (2021)., Competing Interests: The authors declare no competing interests., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
6. Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3.
- Author
-
Nair VP, Liu H, Ciceri G, Jungverdorben J, Frishman G, Tchieu J, Cederquist GY, Rothenaigner I, Schorpp K, Klepper L, Walsh RM, Kim TW, Cornacchia D, Ruepp A, Mayer J, Hadian K, Frishman D, Studer L, and Vincendeau M
- Published
- 2021
- Full Text
- View/download PDF
7. Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascade.
- Author
-
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, and Gurwitz JH
- Subjects
- Aged, Calcium Channel Blockers therapeutic use, Cohort Studies, Diuretics therapeutic use, Female, Humans, Alzheimer Disease drug therapy, Alzheimer Disease epidemiology, Pharmaceutical Preparations
- Abstract
Purpose: Prescribing cascades occur when a physician prescribes a new drug to address the side-effect of another drug. Persons with Alzheimer's disease and related dementias (ADRD) are at increased risk for prescribing cascades. Our objective was to develop an approach to estimating the proportion of calcium channel blocker-diuretic (CCB-diuretic) prescribing cascades among persons with ADRD in two U.S. health plans., Methods: We identified patients aged ≥50 on January 1, 2017, dispensed a drug to treat ADRD in the 365-days prior to/on cohort entry date. Patients had medical/pharmacy coverage for 1 year before and through cohort entry. We excluded individuals with an institutional stay encounter in the 45 days prior to cohort entry and censored patients based on: disenrollment from coverage, death, or end of data. We identified incident and prevalent CCB use in the 183-days following cohort entry, and identified subsequent incident diuretic use among incident and prevalent CCB-users within 365-days from cohort entry., Results: There were 121 538 eligible patients. Approximately 62% were female, with a mean age of 79.5 (SD ±8.6). Overall 2.1% of the cohort experienced a prevalent CCB-diuretic prescribing cascade with 1586 incident diuretic-users among 36 462 prevalent CCB-users (4.3%, 95% CI 4.1-4.6%]); and there were161 incident diuretic-users among 3304 incident CCB-users (4.9%, 95% CI 4.2-5.7%) (incident CCB-diuretic cascade)., Conclusions: We describe an approach to identify prescribing cascades in persons with ADRD, which can be used to assess the proportion of prescribing cascades in large cohorts. We determined the proportion of CCB-diuretic prescribing cascades was low., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
8. Antidopaminergic-Antiparkinsonian Medication Prescribing Cascade in Persons with Alzheimer's Disease.
- Author
-
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, and Gurwitz JH
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease complications, Cohort Studies, Databases, Factual, Female, Humans, Male, Pharmacy statistics & numerical data, Polypharmacy, Practice Patterns, Physicians' statistics & numerical data, United States, Alzheimer Disease drug therapy, Antiparkinson Agents therapeutic use, Dopamine Antagonists therapeutic use, Drug Prescriptions statistics & numerical data
- Abstract
Objectives: Persons living with Alzheimer's disease (AD) may be at increased risk for prescribing cascades due to greater multimorbidity, polypharmacy, and the need for more complex care. Our objective was to assess the proportion of the antidopaminergic-antiparkinsonian medication prescribing cascades among persons living with Alzheimer's disease., Setting: Two large administrative claims databases in the United States., Participants: We identified patients aged ≥50 on January 1, 2017, who were dispensed a drug used to treat Alzheimer's disease for at least 1 day in the 365 days prior to or on cohort entry date and who had medical and pharmacy coverage in the 365 days prior to the cohort entry date. We excluded individuals with a recent institutional stay. We identified incident antidopaminergic (antipsychotic/metoclopramide) use in the 183 days following cohort entry and identified subsequent incident antiparkinsonian drug use within 8 to 365 days., Results: There were 121,538 patients with Alzheimer's disease eligible for inclusion. Approximately 62% were women with a mean age of 79.5 (SD ± 8.6). The mean number of drugs dispensed was 9.2 (SD ± 4.9). There were 36 incident antiparkinsonian users among 4,534 incident antipsychotic/metoclopramide users (0.8%)., Conclusion: We determined that the proportion of antidopaminergic-antiparkinsonian medication prescribing cascades, widely considered as high-priority, was low. Our approach can be used to assess the proportion of prescribing cascades in populations considered to be at high risk and to prioritize system-level interventional efforts to improve medication safety in these patients., (© 2021 The American Geriatrics Society.)
- Published
- 2021
- Full Text
- View/download PDF
9. Category-specific verb-semantic deficits in Alzheimer's disease: Evidence from static and dynamic action naming.
- Author
-
de Almeida RG, Mobayyen F, Antal C, Kehayia E, Nair VP, and Schwartz G
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Alzheimer Disease psychology, Cognition, Movement, Semantics, Vocabulary
- Abstract
We investigated the representation and breakdown of verb knowledge employing different syntactic and semantic classes of verbs in a group of individuals with probable Alzheimer's Disease (pAD). In an action naming task with coloured photographs (Fiez & Tranel, 1997. Standardized stimuli and procedures for investigating the retrieval of lexical and conceptual knowledge for action. Memory and Cognition , 25(4), 543-569. https://doi.org/10.3758/BF03201129), pAD individuals were impaired for naming actions compared to objects. Verb tense was also affected, with simple-past (e.g., chopped ) being more difficult to name than the gerundial form (e.g., chopping ). Employing action-naming with short movies depicting events and states, we contrasted three verb classes based on their hypothetical structural and semantic/conceptual properties: argument structure, thematic structure, and conceptual templates. The three classes were: causatives ( peel ), verbs of perception ( hear ), and verbs of motion ( run ) Overall, results suggest that individuals with pAD are selectively impaired for verb tense and thematic assignment, but not conceptual-template complexity. Methodologically, we also show that dynamic scenes are more ecologically valid than static scenes to probe verb knowledge in AD.
- Published
- 2021
- Full Text
- View/download PDF
10. PCORnet® 2020: current state, accomplishments, and future directions.
- Author
-
Forrest CB, McTigue KM, Hernandez AF, Cohen LW, Cruz H, Haynes K, Kaushal R, Kho AN, Marsolo KA, Nair VP, Platt R, Puro JE, Rothman RL, Shenkman EA, Waitman LR, Williams NA, and Carton TW
- Subjects
- Electronic Health Records statistics & numerical data, Humans, Information Dissemination methods, Pragmatic Clinical Trials as Topic methods, Prospective Studies, Biomedical Research methods, Biomedical Research organization & administration, Information Services organization & administration, Patient Selection, Treatment Outcome
- Abstract
Objective: To describe PCORnet, a clinical research network developed for patient-centered outcomes research on a national scale., Study Design and Setting: Descriptive study of the current state and future directions for PCORnet. We conducted cross-sectional analyses of the health systems and patient populations of the 9 Clinical Research Networks and 2 Health Plan Research Networks that are part of PCORnet., Results: Within the Clinical Research Networks, electronic health data are currently collected from 337 hospitals, 169,695 physicians, 3,564 primary care practices, 338 emergency departments, and 1,024 community clinics. Patients can be recruited for prospective studies from any of these clinical sites. The Clinical Research Networks have accumulated data from 80 million patients with at least one visit from 2009 to 2018. The PCORnet Health Plan Research Network population of individuals with a valid enrollment segment from 2009 to 2019 exceeds 60 million individuals, who on average have 2.63 years of follow-up., Conclusion: PCORnet's infrastructure comprises clinical data from a diverse cohort of patients and has the capacity to rapidly access these patient populations for pragmatic clinical trials, epidemiological research, and patient-centered research on rare diseases., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. The Patient-Centered Outcomes Research Network Antibiotics and Childhood Growth Study: Implementing Patient Data Linkage.
- Author
-
Canterberry M, Kaul AF, Goel S, Lin PD, Block JP, Nair VP, Ma Q, and Carton TW
- Subjects
- Child, Cohort Studies, Electronic Health Records, Female, Humans, Male, Patient Outcome Assessment, Anti-Bacterial Agents therapeutic use, Information Storage and Retrieval
- Abstract
PCORnet, the Patient-Centered Outcomes Research Network, is comprised of health systems and health plans that transform electronic health records (EHRs) and claims data to a common data model (CDM) to facilitate real-world clinical research. Because patients receive health care in multiple care delivery settings, linking health records across systems and health plan claims would provide a more comprehensive and accurate picture of health care for patients. The current study expanded on a PCORnet Antibiotics and Childhood Growth (ABX) study to (1) identify and implement a privacy-preserving patient linkage solution among a clinical data research network and a health plan network within the ABX Study, and (2) assess overlap in prescribed and dispensed antibiotics and additional data gained from claims among the linked patients. This manuscript describes the linkage process and resulting overlap analysis. The authors identified 549 patients from the EHR record study cohort who had claims records with the health plan. Sixty percent (n = 329) of patients had consistent antibiotic exposure data across the 2 sources, indicating antibiotic exposure (44.3%) or nonexposure (15.7%). Among total antibiotic prescribing records, 43.1% had a matched claims record for dispensing within 60 days. Among antibiotic dispense records 26.5% were not associated with a prescribing record in the linked health systems. These findings showcase the feasibility of linking health plan claims data to PCORnet CDM in a privacy-preserving manner while also demonstrating continued gaps in data that may occur. The study highlights the importance of combining multiple health data sources for comprehensive clinical research.
- Published
- 2020
- Full Text
- View/download PDF
12. Prescribing cascades in persons with Alzheimer's disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials.
- Author
-
Bloomstone S, Anzuoni K, Cocoros N, Gurwitz JH, Haynes K, Nair VP, Platt R, Rochon PA, Singh S, and Mazor KM
- Abstract
Introduction: Prescribing cascades occur when the side effect of a drug is misinterpreted as a new medical condition, and a second drug is prescribed to address the side effect. Persons with Alzheimer's disease (AD) are at increased risk of prescribing cascades due to greater multimorbidity, polypharmacy, and complexity of care. The objective of this study was to evaluate educational materials about prescribing cascades in persons with AD, and elicit input on their use in a future trial., Methods: We interviewed community-dwelling adults with either an AD diagnosis or a prescription drug used to treat AD ( n = 12), caregivers of patients meeting the same criteria ( n = 14), and providers ( n = 15). We coded interview transcripts and organized themes according to the communication-human information processing model. We revised the materials based on the interviews, and surveyed participating caregivers and providers for their reactions to the revised materials., Results: Analysis of patients', caregivers', and providers' comments suggest: (a) Providers had conflicting views about the messaging of materials; (b) Caregivers were likely to read letters addressed to patients; (c) Providers were likely to ignore letters, but were receptive to patient/caregiver-initiated conversations; (d) Patients and caregivers had difficulty understanding prescribing cascades; (e) Providers worried that mailed materials would undermine trust; (f) Participants had mixed views on how materials might affect the clinical encounter; (g) Participants felt that materials would improve patient/caregiver engagement. When surveyed, most providers found the revised materials informative and actionable, and most caregivers found them understandable and useful., Conclusions: This evaluation of educational materials about prescribing cascades in patients with AD provides strong support for engaging caregivers to communicate with providers about prescribing cascades. By giving patients and caregivers a basic description of the prescribing cascade concept, our educational materials may help them prepare for a conversation with the provider, who can then tailor the discussion of the possible cascade to the specific needs of the individual patient and caregiver. However, evidence on whether materials can stimulate such conversations awaits testing in a future trial., Lay Summary: Patient, caregiver and provider thoughts on educational materials about prescribing and medication safety Prescribing cascades occur when the side effect of a medication is misinterpreted as a new medical condition, and a second medication is prescribed to treat the side effect. Persons with Alzheimer's disease (AD) are at increased risk of prescribing cascades because they often have more medical conditions, more medications, and more complex care. The goal of this study was to evaluate mailed educational materials about prescribing cascades in persons with AD, and get input on their use in a future study. We interviewed 12 adults with AD, or prescribed a medication to treat AD, 14 caregivers of persons with AD, and 15 providers. We reviewed the interview transcripts to identify important findings about our educational materials. We edited the materials based on the interviews, and sent participating caregivers and providers a questionnaire to get their reactions to the new materials. Important findings from the interviews suggest: (a) Providers had conflicting views about the recommendations given; (b) Caregivers were likely to read letters addressed to patients; (c) Providers were likely to ignore letters, but were receptive to patients/caregivers introducing the topic; (d) Patients and caregivers had difficulty understanding prescribing cascades; (e) Providers worried mailed materials would undermine trust; (f) Participants had mixed views on how materials might affect a doctor's appointment; (g) Participants felt strongly that materials would improve patient/caregiver engagement. When surveyed, almost all providers found the revised materials informative and actionable; and most caregivers found them understandable and useful. These findings provide strong support for engaging caregivers to communicate with providers about prescribing cascades. The educational materials may help patients and caregivers prepare for a conversation with the provider, who can then tailor the discussion of the possible cascade to the specific needs of the individual patient and caregiver. However, evidence on whether materials can stimulate such conversations awaits testing in a future study., Competing Interests: Conflict of interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s), 2020.)
- Published
- 2020
- Full Text
- View/download PDF
13. Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans.
- Author
-
Jutkowitz E, Bynum JPW, Mitchell SL, Cocoros NM, Shapira O, Haynes K, Nair VP, McMahill-Walraven CN, Platt R, and McCarthy EP
- Abstract
Introduction: One-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD-related dementias (AD/ADRD)., Methods: We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date., Results: In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts., Discussion: The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service., (© 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.)
- Published
- 2020
- Full Text
- View/download PDF
14. Cross-Network Directory Service: Infrastructure to enable collaborations across distributed research networks.
- Author
-
Malenfant JM, Hochstadt J, Nolan B, Barrett K, Corriveau D, Dee D, Harris M, Herzig-Marx C, Nair VP, Wyner Z, and Brown JS
- Abstract
Introduction: Existing large-scale distributed health data networks are disconnected even as they address related questions of healthcare research and public policy. This paper describes the design and implementation of a fully functional prototype open-source tool, the Cross-Network Directory Service (CNDS), which addresses much of what keeps distributed networks disconnected from each other., Methods: The set of services needed to implement a Cross-Directory Service was identified through engagement with stakeholders and workgroup members. CNDS was implemented using PCORnet and Sentinel network instances and tested by participating data partners., Results: Web services that enable the four major functional features of the service (registration, discovery, communication, and governance) were developed and placed into an open-source repository. The services include a robust metadata model that is extensible to accommodate a virtually unlimited inventory of metadata fields, without requiring any further software development. The user interfaces are programmatically generated based on the contents of the metadata model., Conclusion: The CNDS pilot project gathered functional requirements from stakeholders and collaborating partners to build a software application to enable cross-network data and resource sharing. The two partners-one from Sentinel and one from PCORnet-tested the software. They successfully entered metadata about their organizations and data sources and then used the Discovery and Communication functionality to find data sources of interest and send a cross-network query. The CNDS software can help integrate disparate health data networks by providing a mechanism for data partners to participate in multiple networks, share resources, and seamlessly send queries across those networks., Competing Interests: Jeff Brown, Jessica Malenfant, Jenny Hochstadt, Kimberly Barrett, Zachary Wyner, Chayim Herzig‐Marx, and Bridget Nolan are employees of Harvard Medical School and Harvard Pilgrim Health Care Institute (HPHCI)‐Department of Population Medicine. They have no conflicts of interest to declare. Software development partners Daniel Dee and Dean Corriveau were employees of Avacoda LLC during the project period. They are now employees of General Dynamics Information Technology, Inc. (GDIT). The principal investigator for the project and subject of the article spoke on behalf of Dee and Corriveau that, as employees of GDIT, they had no conflicts of interest. Through contracts with HPHCI, GDIT supports development of PopMedNet and CNDS software platforms. Marcelline Harris is employed by the University of Michigan; she has no conflict of interest to declare. Vinit Nair is employed by Humana, Inc.; he has no conflict of interest to declare.
- Published
- 2019
- Full Text
- View/download PDF
15. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.
- Author
-
Marco EJ, Aitken AB, Nair VP, da Gente G, Gerdes MR, Bologlu L, Thomas S, and Sherr EH
- Subjects
- Autism Spectrum Disorder psychology, Child, Cohort Studies, Exome genetics, Female, Genetic Predisposition to Disease genetics, Humans, Male, Parents, Siblings, Autism Spectrum Disorder genetics, Autism Spectrum Disorder physiopathology, Mutation, Sensation genetics
- Abstract
Background: In children with sensory processing dysfunction (SPD), who do not meet criteria for autism spectrum disorder (ASD) or intellectual disability, the contribution of de novo pathogenic mutation in neurodevelopmental genes is unknown and in need of investigation. We hypothesize that children with SPD may have pathogenic variants in genes that have been identified as causing other neurodevelopmental disorders including ASD. This genetic information may provide important insight into the etiology of sensory processing dysfunction and guide clinical evaluation and care., Methods: Eleven community-recruited trios (children with isolated SPD and both biological parents) underwent WES to identify candidate de novo variants and inherited rare single nucleotide variants (rSNV) in genes previously associated with ASD. Gene enrichment in these children and their parents for transmitted and non-transmitted mutation burden was calculated. A comparison analysis to assess for enriched rSNV burden was then performed in 2377 children with ASD and their families from the Simons Simplex Collection., Results: Of the children with SPD, 2/11 (18%), were identified as having a de novo loss of function or missense mutation in genes previously reported as causative for neurodevelopmental disorders (MBD5 and FMN2). We also found that the parents of children with SPD have significant enrichment of pathogenic rSNV burden in high-risk ASD candidate genes that are inherited by their affected children. Using the same approach, we confirmed enrichment of rSNV burden in a large cohort of children with autism and their parents but not unaffected siblings., Conclusions: Our findings suggest that SPD, like autism, has a genetic basis that includes both de novo single gene mutations as well as an accumulated burden of rare inherited variants from their parents.
- Published
- 2018
- Full Text
- View/download PDF
16. Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
- Author
-
Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, and Carnahan RM
- Subjects
- Aged, Aged, 80 and over, Atrial Fibrillation complications, Atrial Fibrillation drug therapy, Brain Infarction epidemiology, Brain Infarction etiology, Brain Infarction prevention & control, Factor Xa Inhibitors administration & dosage, Female, Follow-Up Studies, Gastrointestinal Hemorrhage chemically induced, Gastrointestinal Hemorrhage epidemiology, Humans, Intracranial Hemorrhages chemically induced, Intracranial Hemorrhages epidemiology, Male, Middle Aged, Pilot Projects, Prospective Studies, Rivaroxaban administration & dosage, United States epidemiology, Warfarin administration & dosage, Warfarin adverse effects, Adverse Drug Reaction Reporting Systems statistics & numerical data, Factor Xa Inhibitors adverse effects, Rivaroxaban adverse effects, United States Food and Drug Administration statistics & numerical data
- Abstract
Purpose: The US Food and Drug Administration's Sentinel system developed tools for sequential surveillance., Methods: In patients with non-valvular atrial fibrillation, we sequentially compared outcomes for new users of rivaroxaban versus warfarin, employing propensity score matching and Cox regression. A total of 36 173 rivaroxaban and 79 520 warfarin initiators were variable-ratio matched within 2 monitoring periods., Results: Statistically significant signals were observed for ischemic stroke (IS) (first period) and intracranial hemorrhage (ICH) (second period) favoring rivaroxaban, and gastrointestinal bleeding (GIB) (second period) favoring warfarin. In follow-up analyses using primary position diagnoses from inpatient encounters for increased definition specificity, the hazard ratios (HR) for rivaroxaban vs warfarin new users were 0.61 (0.47, 0.79) for IS, 1.47 (1.29, 1.67) for GIB, and 0.71 (0.50, 1.01) for ICH. For GIB, the HR varied by age: <66 HR = 0.88 (0.60, 1.30) and 66+ HR = 1.49 (1.30, 1.71)., Conclusions: This study demonstrates the capability of Sentinel to conduct prospective safety monitoring and raises no new concerns about rivaroxaban safety., (Copyright © 2018 John Wiley & Sons, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
17. Host-Virus Protein Interaction Network Reveals the Involvement of Multiple Host Processes in the Life Cycle of Hepatitis E Virus.
- Author
-
Subramani C, Nair VP, Anang S, Mandal SD, Pareek M, Kaushik N, Srivastava A, Saha S, Shalimar, Nayak B, Ranjith-Kumar CT, and Surjit M
- Abstract
Comprehensive knowledge of host-pathogen interactions is central to understand the life cycle of a pathogen and devise specific therapeutic strategies. Protein-protein interactions (PPIs) are key mediators of host-pathogen interactions. Hepatitis E virus (HEV) is a major cause of viral hepatitis in humans. Recent reports also demonstrate its extrahepatic manifestations in the brain. Toward understanding the molecular details of HEV life cycle, we screened human liver and fetal brain cDNA libraries to identify the host interaction partners of proteins encoded by genotype 1 HEV and constructed the virus-host PPI network. Analysis of the network indicated a role of HEV proteins in modulating multiple host biological processes such as stress and immune responses, the ubiquitin-proteasome system, energy and iron metabolism, and protein translation. Further investigations revealed the presence of multiple host translation regulatory factors in the viral translation/replication complex. Depletion of host translation factors such as eIF4A2, eIF3A, and RACK1 significantly reduced the viral replication, whereas eIF2AK4 depletion had no effect. These findings highlight the ingenuity of the pathogen in manipulating the host machinery to its own benefit, a clear understanding of which is essential for the identification of strategic targets and development of specific antivirals against HEV. IMPORTANCE Hepatitis E virus (HEV) is a pathogen that is transmitted by the fecal-oral route. Owing to the lack of an efficient laboratory model, the life cycle of the virus is poorly understood. During the course of infection, interactions between the viral and host proteins play essential roles, a clear understanding of which is essential to decode the life cycle of the virus. In this study, we identified the direct host interaction partners of all HEV proteins and generated a PPI network. Our functional analysis of the HEV-human PPI network reveals a role of HEV proteins in modulating multiple host biological processes such as stress and immune responses, the ubiquitin-proteasome system, energy and iron metabolism, and protein translation. Further investigations revealed an essential role of several host factors in HEV replication. Collectively, the results from our study provide a vast resource of PPI data from HEV and its human host and identify the molecular components of the viral translation/replication machinery.
- Published
- 2018
- Full Text
- View/download PDF
18. RNA-dependent RNA Polymerase Assay for Hepatitis E Virus.
- Author
-
Nair VP, Anang S, Srivastava A, and Surjit M
- Abstract
RNA-dependent RNA polymerase (RdRp) is essential for the replication of viral RNA for RNA viruses. It synthesizes the complementary strand of viral genomic RNA, which is used subsequently as a template to generate more copies of viral genome. This assay measures activity of the hepatitis E virus (HEV) RdRp. In contrast to protocols available to assay the RdRp activity of many other viruses, this assay utilizes DIG-11-UTP as a nonradioactive alternative to
32 P-UTP, thereby increasing the convenience of performing the assay., (Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.)- Published
- 2017
- Full Text
- View/download PDF
19. RNA Strand Displacement Assay for Hepatitis E Virus Helicase.
- Author
-
Nair VP and Surjit M
- Abstract
The hepatitis E virus (HEV) helicase uses ATP to unwind the RNA duplexes. This is an essential step for viral replication. This protocol aims to measure the double strand RNA unwinding activity of the HEV helicase., (Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.)
- Published
- 2017
- Full Text
- View/download PDF
20. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
- Author
-
Wang W, Hakim MS, Nair VP, de Ruiter PE, Huang F, Sprengers D, Van Der Laan LJ, Peppelenbosch MP, Surjit M, and Pan Q
- Subjects
- Cell Line, Tumor, DNA, Viral genetics, Dose-Response Relationship, Drug, Genotype, HEK293 Cells, Hepacivirus genetics, Hepacivirus growth & development, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic virology, Hepatitis E diagnosis, Hepatitis E virology, Hepatitis E virus genetics, Hepatitis E virus growth & development, Hepatocytes virology, Humans, RNA, Viral genetics, Virus Replication drug effects, Antiviral Agents pharmacology, Hepacivirus drug effects, Hepatitis C, Chronic drug therapy, Hepatitis E drug therapy, Hepatitis E virus drug effects, Hepatocytes drug effects, Sofosbuvir pharmacology
- Published
- 2016
- Full Text
- View/download PDF
21. Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins.
- Author
-
Anang S, Subramani C, Nair VP, Kaul S, Kaushik N, Sharma C, Tiwari A, Ranjith-Kumar CT, and Surjit M
- Subjects
- DNA Mutational Analysis, Hepatitis E virus genetics, Humans, Protein Binding, Protein Interaction Mapping, Hepatitis E virus physiology, Polyproteins metabolism, Viral Proteins metabolism
- Abstract
Hepatitis E virus (HEV) is a major cause of hepatitis in normal and organ transplant individuals. HEV open reading frame-1 encodes a polypeptide comprising of the viral nonstructural proteins as well as domains of unknown function such as the macro domain (X-domain), V, DUF3729 and Y. The macro domain proteins are ubiquitously present from prokaryotes to human and in many positive-strand RNA viruses, playing important roles in multiple cellular processes. Towards understanding the function of the HEV macro domain, we characterized its interaction partners among other HEV encoded proteins. Here, we report that the HEV X-domain directly interacts with the viral methyltransferase and the ORF3 proteins. ORF3 association with the X-domain was mediated through two independent motifs, located within its N-terminal 35aa (amino acids) and C-terminal 63-123aa. Methyltransferase interaction domain was mapped to N-terminal 30-90aa. The X-domain interacted with both ORF3 and methyltransferase through its C-terminal region, involving 66(th),67(th) isoleucine and 101(st),102(nd) leucine, conserved across HEV genotypes. Furthermore, ORF3 and methyltransferase competed with each other for associating with the X-domain. These findings provide molecular understanding of the interaction between the HEV macro domain, methyltransferase and ORF3, suggesting an important role of the macro domain in the life cycle of HEV.
- Published
- 2016
- Full Text
- View/download PDF
22. Prosthetic rehabilitation of surgically treated orbital defects - evisceration, enucleation, and exenteration: A case series.
- Author
-
Babu AS, Manju V, Nair VP, and Thomas CT
- Abstract
The rehabilitation of a patient who has suffered the psychological trauma due to loss of an eye requires a prosthesis that will provide the optimum cosmetic and functional result. The mode of rehabilitation varies based on the type of defect and surgical approach being adopted. A case series of prosthetic rehabilitation of three types of orbital defects - evisceration, enucleation and exenteration have been reported in this article. The clinical relevance of surgical approaches highlights the preservation of remaining anatomic structures creating a negative space or concavity to aid in future prosthetic rehabilitation. A multidisciplinary management and team approach is essential in providing esthetics and to regain the confidence. Follow-up care for the patient is mandatory.
- Published
- 2016
- Full Text
- View/download PDF
23. Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus.
- Author
-
Nair VP, Anang S, Subramani C, Madhvi A, Bakshi K, Srivastava A, Shalimar, Nayak B, Ranjith Kumar CT, and Surjit M
- Subjects
- Cells, Cultured, Genotype, Humans, RNA-Dependent RNA Polymerase genetics, Viral Proteins genetics, DNA Replication genetics, Endoplasmic Reticulum Stress genetics, Hepatitis E virus physiology, RNA, Viral genetics, Virus Replication genetics
- Abstract
Hepatitis E virus (HEV) causes acute hepatitis in many parts of the world including Asia, Africa and Latin America. Though self-limiting in normal individuals, it results in ~30% mortality in infected pregnant women. It has also been reported to cause acute and chronic hepatitis in organ transplant patients. Of the seven viral genotypes, genotype-1 virus infects humans and is a major public health concern in South Asian countries. Sporadic cases of genotype-3 and 4 infection in human and animals such as pigs, deer, mongeese have been reported primarily from industrialized countries. Genotype-5, 6 and 7 viruses are known to infect animals such as wild boar and camel, respectively. Genotype-3 and 4 viruses have been successfully propagated in the laboratory in mammalian cell culture. However, genotype-1 virus replicates poorly in mammalian cell culture and no other efficient model exists to study its life cycle. Here, we report that endoplasmic reticulum (ER) stress promotes genotype-1 HEV replication by inducing cap-independent, internal initiation mediated translation of a novel viral protein (named ORF4). Importantly, ORF4 expression and stimulatory effect of ER stress inducers on viral replication is specific to genotype-1. ORF4 protein sequence is mostly conserved among genotype-1 HEV isolates and ORF4 specific antibodies were detected in genotype-1 HEV patient serum. ORF4 interacted with multiple viral and host proteins and assembled a protein complex consisting of viral helicase, RNA dependent RNA polymerase (RdRp), X, host eEF1α1 (eukaryotic elongation factor 1 isoform-1) and tubulinβ. In association with eEF1α1, ORF4 stimulated viral RdRp activity. Furthermore, human hepatoma cells that stably express ORF4 or engineered proteasome resistant ORF4 mutant genome permitted enhanced viral replication. These findings reveal a positive role of ER stress in promoting genotype-1 HEV replication and pave the way towards development of an efficient model of the virus.
- Published
- 2016
- Full Text
- View/download PDF
24. Effect of Impurities on the Josephson Current through Helical Metals: Exploiting a Neutrino Paradigm.
- Author
-
Ghaemi P and Nair VP
- Abstract
In this Letter we study the effect of time-reversal symmetric impurities on the Josephson supercurrent through two-dimensional helical metals such as on a topological insulator surface state. We show that, contrary to the usual superconducting-normal metal-superconducting junctions, the suppression of the supercurrent in the superconducting-helical metal-superconducting junction is mainly due to fluctuations of impurities in the junctions. Our results, which are a condensed matter realization of a part of the Mikheyev-Smirnov-Wolfenstein effect for neutrinos, show that the relationship between normal state conductance and the critical current of Josephson junctions is significantly modified for Josephson junctions on the surface of topological insulators. We also study the temperature dependence of the supercurrent and present a two fluid model which can explain some of the recent experimental results in Josephson junctions on the edge of topological insulators.
- Published
- 2016
- Full Text
- View/download PDF
25. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
- Author
-
Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, and Bate A
- Subjects
- Cohort Studies, Drug-Related Side Effects and Adverse Reactions diagnosis, Humans, Databases, Factual statistics & numerical data, Drug-Related Side Effects and Adverse Reactions epidemiology, Electronic Health Records statistics & numerical data, Product Surveillance, Postmarketing statistics & numerical data, Sentinel Surveillance
- Abstract
Introduction: An often key component to coordinating surveillance activities across distributed networks is the design and implementation of a common data model (CDM). The purpose of this study was to evaluate two drug safety surveillance CDMs from an ecosystem perspective to better understand how differences in CDMs and analytic tools affect usability and interpretation of results., Methods: Humana claims data from 2007 to 2012 were mapped to Observational Medical Outcomes Partnership (OMOP) and Mini-Sentinel CDMs. Data were described and compared at the patient level by source code and mapped concepts. Study cohort construction and effect estimates were also compared using two different analytical methods--one based on a new user design implementing a high-dimensional propensity score (HDPS) algorithm and the other based on univariate self-controlled case series (SCCS) design--across six established positive drug-outcome pairs to learn how differences in CDMs and analytics influence steps in the database analytic process and results., Results: Claims data for approximately 7.7 million Humana health plan members were transformed into the two CDMs. Three health outcome cohorts and two drug cohorts showed differences in cohort size and constituency between Mini-Sentinel and OMOP CDMs, which was a result of multiple factors. Overall, the implementation of the HDPS procedure on Mini-Sentinel CDM detected more known positive associations than that on OMOP CDM. The SCCS method results were comparable on both CDMs. Differences in the implementation of the HDPS procedure between the two CDMs were identified; analytic model and risk period specification had a significant impact on the performance of the HDPS procedure on OMOP CDM., Conclusions: Differences were observed between OMOP and Mini-Sentinel CDMs. The analysis of both CDMs at the data model level indicated that such conceptual differences had only a slight but not significant impact on identifying known safety associations. Our results show that differences at the ecosystem level of analyses across the CDMs can lead to strikingly different risk estimations, but this can be primarily attributed to the choices of analytic approach and their implementation in the community-developed analytic tools. The opportunities of using CDMs are clear, but our study shows the need for judicious comparison of analyses across the CDMs. Our work emphasizes the need for ongoing efforts to ensure sustainable transparent platforms to maintain and develop CDMs and associated tools for effective safety surveillance.
- Published
- 2015
- Full Text
- View/download PDF
26. Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
- Author
-
Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, and Bate A
- Published
- 2015
- Full Text
- View/download PDF
27. Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program.
- Author
-
Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA, and Gurwitz JH
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, International Classification of Diseases, Male, Middle Aged, Myocardial Infarction epidemiology, Outcome Assessment, Health Care methods, Predictive Value of Tests, Reproducibility of Results, United States, United States Food and Drug Administration, Algorithms, Databases, Factual statistics & numerical data, Myocardial Infarction diagnosis
- Abstract
Purpose: To validate an algorithm based upon International Classification of Diseases, 9(th) revision, Clinical Modification (ICD-9-CM) codes for acute myocardial infarction (AMI) documented within the Mini-Sentinel Distributed Database (MSDD)., Methods: Using an ICD-9-CM-based algorithm (hospitalized patients with 410.x0 or 410.x1 in primary position), we identified a random sample of potential cases of AMI in 2009 from four Data Partners participating in the Mini-Sentinel Program. Cardiologist reviewers used information abstracted from hospital records to assess the likelihood of an AMI diagnosis based on criteria from the Joint European Society of Cardiology and American College of Cardiology Global Task Force. Positive predictive values (PPVs) of the ICD-9-based algorithm were calculated., Results: Of the 153 potential cases of AMI identified, hospital records for 143 (93%) were retrieved and abstracted. Overall, the PPV was 86.0% (95% confidence interval; 79.2%, 91.2%). PPVs ranged from 76.3% to 94.3% across the four Data Partners., Conclusions: The overall PPV of potential AMI cases, as identified using an ICD-9-CM-based algorithm, may be acceptable for safety surveillance; however, PPVs do vary across Data Partners. This validation effort provides a contemporary estimate of the reliability of this algorithm for use in future surveillance efforts conducted using the Food and Drug Administration's MSDD., (Copyright © 2012 John Wiley & Sons, Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
28. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program.
- Author
-
Forrow S, Campion DM, Herrinton LJ, Nair VP, Robb MA, Wilson M, and Platt R
- Subjects
- Confidentiality legislation & jurisprudence, Cooperative Behavior, Humans, Intellectual Property, Pilot Projects, Program Development methods, United States, Organizational Policy, Product Surveillance, Postmarketing methods, United States Food and Drug Administration
- Abstract
The US Food and Drug Administration's Mini-Sentinel pilot program is developing an organizational structure as well as principles and policies to govern its operations. These will inform the structure and function of the eventual Sentinel System. Mini-Sentinel is a collaboration that includes 25 participating institutions. We describe the program's current organizational structure and its major principles and policies. The organization includes a coordinating center with program leadership provided by a principal investigator; a planning board and subcommittees; an operations center; and data, methods, and protocol cores. Ad hoc workgroups are created as needed. A privacy panel advises about protection of individual health information. Principles and policies are intended to ensure that Mini-Sentinel conforms to the principles of fair information practices, protects the privacy of individual health information, maintains the security and integrity of data, assures the confidentiality of proprietary information, provides accurate and timely communications, prevents or manages conflicts of interest, and preserves respect for intellectual property rights., (Copyright © 2012 John Wiley & Sons, Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
29. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
- Author
-
Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, Raebel MA, Beaulieu NU, Rosofsky R, Woodworth TS, and Brown JS
- Subjects
- Biological Products adverse effects, Drug-Related Side Effects and Adverse Reactions, Equipment and Supplies adverse effects, Feasibility Studies, Humans, Models, Theoretical, Pilot Projects, Program Development, Software, United States, Databases, Factual, Product Surveillance, Postmarketing methods, United States Food and Drug Administration
- Abstract
Purpose: We describe the design, implementation, and use of a large, multiorganizational distributed database developed to support the Mini-Sentinel Pilot Program of the US Food and Drug Administration (FDA). As envisioned by the US FDA, this implementation will inform and facilitate the development of an active surveillance system for monitoring the safety of medical products (drugs, biologics, and devices) in the USA., Methods: A common data model was designed to address the priorities of the Mini-Sentinel Pilot and to leverage the experience and data of participating organizations and data partners. A review of existing common data models informed the process. Each participating organization designed a process to extract, transform, and load its source data, applying the common data model to create the Mini-Sentinel Distributed Database. Transformed data were characterized and evaluated using a series of programs developed centrally and executed locally by participating organizations. A secure communications portal was designed to facilitate queries of the Mini-Sentinel Distributed Database and transfer of confidential data, analytic tools were developed to facilitate rapid response to common questions, and distributed querying software was implemented to facilitate rapid querying of summary data., Results: As of July 2011, information on 99,260,976 health plan members was included in the Mini-Sentinel Distributed Database. The database includes 316,009,067 person-years of observation time, with members contributing, on average, 27.0 months of observation time. All data partners have successfully executed distributed code and returned findings to the Mini-Sentinel Operations Center., Conclusion: This work demonstrates the feasibility of building a large, multiorganizational distributed data system in which organizations retain possession of their data that are used in an active surveillance system., (Copyright © 2012 John Wiley & Sons, Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
30. Penetration of medication safety technology in community hospitals.
- Author
-
Schumock GT, Nair VP, Finley JM, and Lewis RK
- Subjects
- Hospitals, Community organization & administration, Medical Records Systems, Computerized statistics & numerical data, Pharmacists organization & administration, Medication Errors prevention & control, Medication Systems, Hospital organization & administration, Safety Management methods
- Abstract
Results of a survey of medication safety technology in community hospitals are presented. A written questionnaire was mailed to pharmacy directors at 88 hospitals located in 21 states. Items in the questionnaire addressed current and planned use of technology intended to improve medication safety. Fifty-six usable responses were received for a response rate of 63.6%. Medication safety was considered one of the most important issues facing pharmacy departments. Barriers identified by respondents to the implementation of medication safety initiatives included lack of time and personnel. Most hospitals had implemented one or more different types of medication safety technology. Computer-generated or electronic medication administration records, pharmacy computer systems interfaced with laboratory values, and unit-based medication dispensing cabinets were the most common medication safety technologies used. Pharmacy managers perceived these technologies to have resulted in a reduction in the rate of medication errors in respondent hospitals.
- Published
- 2003
- Full Text
- View/download PDF
31. Level quantization for the noncommutative Chern-Simons theory.
- Author
-
Nair VP and Polychronakos AP
- Abstract
We show that the coefficient of the three-dimensional Chern-Simons action on the noncommutative plane must be quantized. Similar considerations apply in other dimensions as well.
- Published
- 2001
- Full Text
- View/download PDF
32. Comment on "Anyon in an external electromagnetic field: Hamiltonian and Lagrangian formulations"
- Author
-
Jackiw R and Nair VP
- Published
- 1994
- Full Text
- View/download PDF
33. Hamiltonian analysis of the effective action for hard thermal loops in QCD.
- Author
-
Nair VP
- Published
- 1994
- Full Text
- View/download PDF
34. High-temperature response functions and the non-Abelian Kubo formula.
- Author
-
Jackiw R and Nair VP
- Published
- 1993
- Full Text
- View/download PDF
35. Hard thermal loops, gauged WZNW action, and the energy of hot quark-gluon plasma.
- Author
-
Nair VP
- Published
- 1993
- Full Text
- View/download PDF
36. Chern-Simons theory and the quark-gluon plasma.
- Author
-
Efraty R and Nair VP
- Published
- 1993
- Full Text
- View/download PDF
37. Action for the hot gluon plasma based on the Chern-Simons theory.
- Author
-
Efraty R and Nair VP
- Published
- 1992
- Full Text
- View/download PDF
38. Black holes in magnetic monopoles.
- Author
-
Lee K, Nair VP, and Weinberg EJ
- Published
- 1992
- Full Text
- View/download PDF
39. A classical instability of Reissner-Nordström solutions and the fate of magnetically charged black holes.
- Author
-
Lee K, Nair VP, and Weinberg EJ
- Published
- 1992
- Full Text
- View/download PDF
40. Relativistic wave equation for anyons.
- Author
-
Jackiw R and Nair VP
- Published
- 1991
- Full Text
- View/download PDF
41. QCD vacuum as a chromomagnetic superconductor: Microscopic physics.
- Author
-
Nair VP and Rosenzweig C
- Published
- 1985
- Full Text
- View/download PDF
42. The merciless sun.
- Author
-
Nair VP
- Subjects
- Adult, Humans, Male, Sunstroke therapy, Sunstroke diagnosis
- Published
- 1978
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.